Media

Press Kit

Malin Media Pack

> Coming Soon

Reports & Presentations

2020 Interim Report

> download > go to Reports & Presentations page

Latest Press Releases

RNS Announcements

Investee Companies

Wed, 02 Sep 2020

Malin Announces 2020 Interim Results

Tue, 11 Aug 2020

Kymab reports positive Phase 2a data

Tue, 11 Aug 2020

Notice of 2020 interim results

Fri, 10 Jul 2020

Poseida Prices Nasdaq IPO

Thu, 02 Jul 2020

Result of AGM

News Archive>

21 Oct 2020

Mycovia Pharmaceuticals, Inc. Announces Last Patient Completes Final Visit in their Global Phase 3 “VIOLET Studies” for Oteseconazole (VT-1161) for the treatment of recurrent vulvovaginal candidiasis (RVVC)

21 Oct 2020

Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19

15 Oct 2020

Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director

28 Sep 2020

Wren Therapeutics Announces Publication in Nature Research Journal

18 Sep 2020

Poseida Therapeutics Added to Membership of US Small-Cap Russell 2000® Index

Media Contacts

Malin Media Contact

Tel: +353 (0)1 901 5717

mediarelations@malinplc.com
Ireland - Financial Media Contact

Powerscourt

Tel: +353 (0)1 536 0682

malin@powerscourt-group.com
UK - Financial Media Contact

Consilium Strategic Communications

Tel: +44 (0)20 3709 5700

malin@consilium-comms.com